Interestingly, we also found that IL6Rα expression was negatively correlated with pSTAT3 response to IL-10, indicating that heightened IL6Rα and IL-6 in cancer patients may be dominating STAT3 signaling and in turn suppressing the IL-10 responsiveness. Here, STAT3 is linked to cancer.